Update on hepatocellular carcinoma: Pathologists’ review T El Jabbour, SM Lagana, H Lee World journal of gastroenterology 25 (14), 1653, 2019 | 146 | 2019 |
PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and-proficient colorectal cancer: the foundation study using the SP142 antibody … T El Jabbour, JS Ross, CE Sheehan, KE Affolter, KB Geiersbach, ... Journal of Clinical Pathology 71 (1), 46-51, 2018 | 28 | 2018 |
Possible risk factors for candida esophagitis in immunocompetent individuals Y Nassar, T Eljabbour, H Lee, A Batool Gastroenterology Research 11 (3), 195, 2018 | 22 | 2018 |
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study H Lee, T El Jabbour, S Ainechi, LM Gay, JA Elvin, JA Vergilio, J Suh, ... Human pathology 70, 84-91, 2017 | 22 | 2017 |
Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent CA Castrodad-Rodríguez, NC Panarelli, AJ Gersten, Q Liu, M Feely, ... Modern Pathology 33 (8), 1581-1588, 2020 | 13 | 2020 |
Features That Aid Identification of Autoimmune Gastritis in a Background of Active Helicobacter pylori Infection J Choudhuri, S Hall, CA Castrodad-Rodriguez, M Westerhoff, ... Archives of Pathology & Laboratory Medicine 145 (12), 1536-1543, 2021 | 10 | 2021 |
Kenny-Caffey syndrome type 1 T El Jabbour, T Aboursheid, MB Keifo, I Maksoud, D Alasmar Avicenna Journal of Medicine 4 (03), 74-76, 2014 | 9 | 2014 |
Ophthalmologic impairment and intellectual disability in a girl presenting Kenny-Caffey syndrome type 2 D Deconte, TC Kreusch, BP Salvaro, WF Perin, MAT Ferreira, C Kopacek, ... Journal of Pediatric Genetics 9 (04), 263-269, 2020 | 8 | 2020 |
Benign vs malignant pancreatic lesions: molecular insights to an ongoing debate M Aldyab, T El Jabbour, M Parilla, H Lee World Journal of Gastrointestinal Surgery 13 (5), 406, 2021 | 6 | 2021 |
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications T El Jabbour, M Misyura, D Cowzer, M Zimmermann, V Rimkunas, ... JNCI: Journal of the National Cancer Institute 114 (5), 761-770, 2022 | 5 | 2022 |
Increased cytoplasmic yes-associated protein (YAP) expression in mismatch repair protein-proficient colorectal cancer with high-grade tumor budding and reduced autophagy activity M Mikula, S Najjar, T El Jabbour, S Dalvi, K Umrau, H Li, BH Koo, H Lee Applied Immunohistochemistry & Molecular Morphology 29 (4), 305-312, 2021 | 4 | 2021 |
Clinical significance of pathologic abnormalities in biopsy samples from the appendiceal orifice CA Castrodad‐Rodríguez, J Choudhuri, T El‐Jabbour, J Cheng, ... Histopathology 79 (5), 751-757, 2021 | 3 | 2021 |
Histologic lesions of Porto-Sinusoidal Vascular Disease following phlebotomy in hemochromatosis T El Jabbour, KE McHugh, DT Patil, C Zuo, BH Koo, S Kim, H Lee Gastroenterology Research 13 (1), 32, 2020 | 3 | 2020 |
Coexpression of CDX2 and CK20 in hepatocellular carcinoma, an exceedingly rare co-incidence with potential diagnostic pitfall. T El Jabbour, N Durie, H Lee Human Pathology 81, 298-298, 2018 | 3 | 2018 |
Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine A Molnar, H Monroe, H Basri Aydin, ME Arslan, A Lightle, H Lee, ... Current Oncology 30 (2), 2388-2404, 2023 | 2 | 2023 |
Metastatic insulinoma presenting as a liver cyst H Li, T El Jabbour, A Nigam, H Lee Journal of Pathology and Translational Medicine 53 (2), 148-151, 2019 | 2 | 2019 |
Myeloid cell leukemia-1 protein expression and myeloid cell leukemia-1 gene amplification in non small cell lung cancer T El Jabbour, SD Dalvi, S Kim, C Sheehan, JS Ross Indian Journal of Pathology and Microbiology 61 (1), 27-30, 2018 | 2 | 2018 |
Challenges in diagnosing and reporting cholangiocarcinoma T El Jabbour, A Molnar, SM Lagana Surgical Pathology Clinics 16 (3), 599-608, 2023 | 1 | 2023 |
Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas JK Benhamida, M Vyas, A Tanaka, L Wang, A Bahrami, K Ozcan, ... Modern Pathology 35 (7), 956-961, 2022 | 1 | 2022 |
Recurrent loss of heterozygosity in pancreatic neuroendocrine tumors M Parilla, D Chapel, JF Hechtman, P Wanjari, T El Jabbour, A Sharma, ... The American journal of surgical pathology 46 (6), 823-831, 2022 | 1 | 2022 |